IBEC in the Media
Pau Gorostiza and cochlear implants in the media
Pau Gorostiza, principal investigator at IBEC and ICREA profesor, appears in the media for his study co-led with Tobias Moser, director of the Institute for Auditory Neuroscience. The study presents the first light-controlled drug that produces auditory stimulation in vivo without the need of genetic manipulation.
Alternatives to animal experimentation with Núria Montserrat
IBEC principal investigator and ICREA professor Núria Montserrat appears on the TV3 news program talking about alternatives to animal experimentation.
Samuel Sanchez and nanorobots in the media
Samuel Sánchez, principal investigator at IBEC appears in the media for his co-led study with César de la Fuente-Núñez of the University of Pennsylvania, USA, on the development of nanorobots to fight bacterial infections.
Samuel Sanchez and nanorobots in the media
Samuel Sánchez, principal investigator at IBEC appears in the media for his co-led study with César de la Fuente-Núñez of the University of Pennsylvania, USA, on the development of nanorobots to fight bacterial infections.
Mini-kidneys, diabetes and COVID-19 in the media
Núria Montserrat, ICREA Research Professor at IBEC, appears in the media for her breakthrough between diabetes and COVID-19 thanks to human mini-kidneys created in the lab.
Núria Montserrat and science in the newspaper “El País”
Núria Montserrat, principal investigator at the Institute for Bioengineering of Catalonia (IBEC), is featured in the newspaper “El País” for her work on the development of organoids through pluripotent stem cells that, in the future, could be used for transplants.
Bioengineering in rural schools
The Institute for Bioengineering of Catalonia (IBEC) is featured in the ARA newspaper for its innovative project that brings bioengineering to rural schools.
Núria Montserrat in “The transplant chimera”
Núria Montserrat, principal investigator at IBEC, appears on RTVE’s “REPOR” program, where she talks about using mini-organs to identify new therapeutic therapies and new drugs.
Bioengineering to treat diabetes in the media
